Old Web
English
Sign In
Acemap
>
authorDetail
>
Pedro A. Garcia‐Hernandez
Pedro A. Garcia‐Hernandez
double blind
Placebo-controlled study
Liraglutide
Lira
Medicine
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Liraglutide as add-on to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial
2020
Diabetes, Obesity and Metabolism
Lawrence Blonde
Lidia Belousova
Udi Fainberg
Pedro A. Garcia‐Hernandez
Sunil M Jain
Margit S. Kaltoft
Ofri Mosenzon
Jalal Nafach
Mads Sundby Palle
Rosangela Rea
Show All
Source
Cite
Save
Citations (14)
OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled Trial
2019
Journal of the Endocrine Society
Lawrence Blonde
Lidia Belousova
Udi Fainberg
Pedro A. Garcia‐Hernandez
Sunil M Jain
Margit S. Kaltoft
Ofri Mosenzon
Jalal Nafach
Mads Sundby Palle
Rosangela Rea
Show All
Source
Cite
Save
Citations (0)
1